Company news
Sansure Biotech Inc. Class A (SSE:688289) news
Sansure Biotech Inc. Class A news releases on 6ix. Latest, Jul 12, 2025: Announcement on Term Change and Election of Board of Directors
Press releases — page 2
Announcement on Term Change and Election of Board of Directors
July 11, 2025
Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Product
June 23, 2025
Announcement on Accepting Partial Equity of Hunan Shengwei Sirui Biotechnology Co., Ltd. and Joint Investment with Related Parties
June 12, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 4, 2025
Announcement on the Phased Progress in Acquiring Equity of Zhongshan Sansure Hygene Biomedicine Co., Ltd.
May 23, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 16, 2025
Announcement on Capital Increase of Hunan Shengwei Kunteng Biotechnology Co., Ltd. and Joint Investment with Related Parties
May 8, 2025
Full Text of 2024 Annual Report
April 28, 2025